Middle East Pharmaceutical Industries Co. 2026 Annual Results
Middle East Pharmaceutical Industries Co. (4016) reported full year 2026 revenue of . Net profit came in at . All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.
Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2026-05-14.